Drug Target Review

SEPTEMBER 22, 2023

The substantial value of organoids is becoming increasingly recognised by supportive government initiatives developing novel drugs, with a growth rate of 22 percent between 2023 and 2030 and a market size predicted to reach over US $6.5 billion by 2030. Front Genet. 2021;12(November):1–14. Nat Rev Methods Prim [Internet].

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. billion by 2030 at a compound annual growth rate (CAGR) of 7.5%

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

PPD

OCTOBER 18, 2023

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. 1 With this growth comes increased demands for laboratory services at all steps across the development process.

Laboratories 52

Laboratories Assay Development Small Molecule Drug Development 52

Vial

FEBRUARY 8, 2024

To advance new therapies, pharmaceutical, biotech, and medical device companies engage contract research organizations (CROs) for their know-how in navigating the complex landscape of drug development and regulatory pathways and to run clinical trials. billion in 2030. As von Itzstein et al.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

Vial

FEBRUARY 15, 2024

According to the 2022 Polaris Market Research Report , the global clinical trials outsourcing market reached USD 38.11 over the forecast period (2022-2030). This article discusses current challenges in managing clinical trials and elucidates the pivotal role that CROs play in overcoming these obstacles.

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

Vial

APRIL 18, 2024

The urgency for novel therapeutic approaches makes ophthalmology a rapidly growing domain of clinical research. Market research indicates significant growth in the ophthalmic clinical trials market, driven by increased disease prevalence, demand for ocular treatments, and rising research funding. from 2023 to 2030.

Clinical Trials 52

Clinical Trials Trials Treatment Clinical Research 52

Vial

MARCH 27, 2024

According to a report by Grand View Research, the global CRO services market was valued at approximately US$50.55 from 2024 to 2030. Personnel salaries, site rentals, and equipment maintenance are other necessary expenses associated with clinical trials.

Clinical Trials 52

Clinical Trials Trials International Compliance 52